share_log

HSBC Upgrades Gilead Sciences to Hold, Announces $69 Price Target

Moomoo 24/7 ·  Apr 24 13:54

HSBC analyst Morten Herholdt upgrades Gilead Sciences (NASDAQ:GILD) from Reduce to Hold and announces $69 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment